OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 25, pp. 2317-2330
Open Access | Times Cited: 283
Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 25, pp. 2317-2330
Open Access | Times Cited: 283
Showing 1-25 of 283 citing articles:
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 11, pp. 990-1004
Closed Access | Times Cited: 49
Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 11, pp. 990-1004
Closed Access | Times Cited: 49
Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial
Evan S. Dellon, Kathryn A. Peterson, Benjamin Mitlyng, et al.
Gut (2023) Vol. 72, Iss. 10, pp. 1828-1837
Closed Access | Times Cited: 47
Evan S. Dellon, Kathryn A. Peterson, Benjamin Mitlyng, et al.
Gut (2023) Vol. 72, Iss. 10, pp. 1828-1837
Closed Access | Times Cited: 47
Engineering the IL ‐4/IL ‐13 axis for targeted immune modulation
Zachary J. Bernstein, Anjali Shenoy, Amy Chen, et al.
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 29-57
Open Access | Times Cited: 43
Zachary J. Bernstein, Anjali Shenoy, Amy Chen, et al.
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 29-57
Open Access | Times Cited: 43
S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023
Marek Lommatzsch, Carl-Peter Criée, Carmen C.M. de Jong, et al.
Pneumologie (2023) Vol. 77, Iss. 08, pp. 461-543
Open Access | Times Cited: 43
Marek Lommatzsch, Carl-Peter Criée, Carmen C.M. de Jong, et al.
Pneumologie (2023) Vol. 77, Iss. 08, pp. 461-543
Open Access | Times Cited: 43
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
Mirna Chehade, Evan S. Dellon, Jonathan M. Spergel, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2239-2251
Closed Access | Times Cited: 33
Mirna Chehade, Evan S. Dellon, Jonathan M. Spergel, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2239-2251
Closed Access | Times Cited: 33
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2252-2263
Closed Access | Times Cited: 28
Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2252-2263
Closed Access | Times Cited: 28
Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
Roberto Berni Canani, Marco Caminati, Laura R. Carucci, et al.
Allergy (2024) Vol. 79, Iss. 6, pp. 1485-1500
Open Access | Times Cited: 19
Roberto Berni Canani, Marco Caminati, Laura R. Carucci, et al.
Allergy (2024) Vol. 79, Iss. 6, pp. 1485-1500
Open Access | Times Cited: 19
Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Jorge Amil Dias, Salvatore Oliva, Αλεξάνδρα Παπαδοπούλου, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 2, pp. 394-437
Closed Access | Times Cited: 19
Jorge Amil Dias, Salvatore Oliva, Αλεξάνδρα Παπαδοπούλου, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 2, pp. 394-437
Closed Access | Times Cited: 19
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management
William Shomali, Jason Gotlib
American Journal of Hematology (2024) Vol. 99, Iss. 5, pp. 946-968
Open Access | Times Cited: 16
William Shomali, Jason Gotlib
American Journal of Hematology (2024) Vol. 99, Iss. 5, pp. 946-968
Open Access | Times Cited: 16
ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 7
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 7
Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
Clinical guidance for the use of dupilumab in eosinophilic esophagitis
Seema S. Aceves, Evan S. Dellon, Matthew Greenhawt, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 3, pp. 371-378
Closed Access | Times Cited: 53
Seema S. Aceves, Evan S. Dellon, Matthew Greenhawt, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 3, pp. 371-378
Closed Access | Times Cited: 53
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
Kara Kliewer, Cristin Murray-Petzold, Margaret H. Collins, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 803-815
Open Access | Times Cited: 38
Kara Kliewer, Cristin Murray-Petzold, Margaret H. Collins, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 803-815
Open Access | Times Cited: 38
Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis
Pierfrancesco Visaggi, Brigida Barberio, Giulio Del Corso, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2019-2030
Open Access | Times Cited: 35
Pierfrancesco Visaggi, Brigida Barberio, Giulio Del Corso, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2019-2030
Open Access | Times Cited: 35
Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases
Brian Kim, Marc E. Rothenberg, Xin Sun, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 879-893
Open Access | Times Cited: 35
Brian Kim, Marc E. Rothenberg, Xin Sun, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 879-893
Open Access | Times Cited: 35
Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis
Chris Lee, Evan S. Dellon
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 2, pp. 252-258
Closed Access | Times Cited: 32
Chris Lee, Evan S. Dellon
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 2, pp. 252-258
Closed Access | Times Cited: 32
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 7, pp. 1173-1184
Closed Access | Times Cited: 14
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 7, pp. 1173-1184
Closed Access | Times Cited: 14
Dupilumab: Mechanism of action, clinical, and translational science
Marc R. McCann, Matthew P. Kosloski, Christine Xu, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 10
Marc R. McCann, Matthew P. Kosloski, Christine Xu, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 10
Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13
Mia Y. Masuda, Grace C. Pyon, Huijun Luo, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1355-1368
Open Access | Times Cited: 8
Mia Y. Masuda, Grace C. Pyon, Huijun Luo, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1355-1368
Open Access | Times Cited: 8
Dupilumab induced ocular surface diseases: an analysis of FAERS database, literature review and disease-gene interaction networks
Jiaojiao Chen, Huixiang Li, Huiyuan Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
Jiaojiao Chen, Huixiang Li, Huiyuan Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Masato Tamari, Aaron Ver Heul
Allergology International (2025)
Open Access | Times Cited: 1
Masato Tamari, Aaron Ver Heul
Allergology International (2025)
Open Access | Times Cited: 1
An update on the diagnosis and management of non‐IgE‐mediated food allergies in children
Rosan Meyer, Antonella Cianferoni, Marta Vázquez‐Ortiz
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 3
Closed Access | Times Cited: 1
Rosan Meyer, Antonella Cianferoni, Marta Vázquez‐Ortiz
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 3
Closed Access | Times Cited: 1
Letter: Disappearing Microbe, Emerging Disease? Nuancing the Protective Effects of Helicobacter pylori Against Eosinophilic Oesophagitis
Enzo Emanuele, Piercarlo Minoretti
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Enzo Emanuele, Piercarlo Minoretti
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Learning to fake it: limited responses and fabricated references provided by ChatGPT for medical questions
Jocelyn Gravel, Madeleine D’Amours-Gravel, Esli Osmanlliu
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
Jocelyn Gravel, Madeleine D’Amours-Gravel, Esli Osmanlliu
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
